EUVIMEDEUVIMED entdecken
Crossref

Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury

Siyi Zhou iD, Jiayi Liu, Manli Hu iD, Song Tian iD, Junjie Zhou iD, Wei Li, Hailian Chen, Maoji Yin iD, Shiyi Wang, Lei Luo iD, Long Zhang iD, Xiangqiang Zhou und 18 weitere

Circulation · 2026

DOI: 10.1161/circulationaha.125.077971 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2026. Verfasst von Siyi Zhou und 29 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institut…. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Lysosomes, Myocytes, Cardiac, Autophagosomes. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Myocardial ischemia-reperfusion (MIR) injury compromises therapeutic effects of revascularization and leads to functional impairment and exacerbation of structural damage in the heart. Limiting the damage caused by MIR is crucial but is still an unmet clinical need because of the complexity of the underlying mechanisms. Increasing evidence suggests that lysosomal autophagy plays a significant regulatory role in MIR injury. The specific mechanisms involved remain to be fully understood. METHODS: We here systematically analyzed the murine MIR model database to screen the potentially protective lysosome-localized proteins against MIR injury. The positive hits were further functionally screened and validated for their capability on autophagy and hypoxia/reoxygenation insults of cardiomyocytes. After exploring the detailed molecular mechanism underlying the protective effects of the target protein, we generated target gene cardiac-specific knockout mice and overexpression mice to verify its function in mouse MIR injury models. RESULTS: LAPTM4A (lysosome-associated protein transmembrane 4 alpha) stood out as a significant protective lysosome-localized protein from the screening. LAPTM4A deficiency significantly heightened the inflammatory response and cell death both in primary cardiomyocytes and in a MIR-induced mouse model. Conversely, LAPTM4A overexpression exerted protective effects on cell viability and myocardial damage. Mechanistically, LAPTM4A interacts with Rubicon (Run domain Beclin1-interacting and cysteine-rich domain–containing protein), hindering its engagement within the Beclin1 complex, resulting in a robust augmentation of autophagic flux and thereby mitigating cardiac damage during reperfusion. It is important to note that Rubicon knockdown markedly reversed the aggravated injury induced by LAPTM4A knockdown, further verifying the effects of LAPTM4A depend on Rubicon. CONCLUSIONS: Our findings screened out and validated that LAPTM4A is a lysosome-localized protein exerting protective effects against MIR injury by facilitating autophagic flux. Targeting LAPTM4A represents a promising therapeutic strategy for mitigating MIR injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Reperfusion InjuryLysosomesMyocytes, CardiacAutophagosomesMembrane ProteinsMembrane FusionOncogene ProteinsAnimalsMiceMice, KnockoutAutophagyIntracellular Signaling Peptides and ProteinsMice, Inbred C57BLAutophagy-Related ProteinsMaleCells, CulturedDisease Models, AnimalHumans

Stichwörter der Autor:innen

LAPTM4ARubiconautophagylysosomal membrane proteinmyocardial ischemic reperfusion injury

Substanzen

Rubcn protein, mouseMembrane ProteinsIntracellular Signaling Peptides and ProteinsAutophagy-Related ProteinsOncogene Proteins

Autor:innen und Institutionen

  • State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute, School of Pharmacy, First Affiliated Hospital, Gannan Medical Unive…
  • Department of Colorectal and Anal Surgery (Clinical Center for Pelvic Floor Surgery), Zhongnan Hospital of Wuhan University, China (S.Z.).
  • Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, Hubei Provincial Engineering Research Center of Minimally Invasive Cardiovascular Surgery, Wuhan Clinical Research Center for Minimally Invasi…
  • Department of Cardiology, Renmin Hospital, Wuhan University, China (J.L., W.L., M.Y., L.L., L.Z., Z.-G.S.).
  • TargetHunter PharmaTech (Jiangxi) Co, Ltd, Ganzhou, China (X.C., Q.Q., J. Wang).
  • Department of Cardiology, Zhongnan Hospital of Wuhan University, Institute of Myocardial Injury and Repair, Wuhan University, China (W.Q.).

ORCID-Profile: Siyi Zhou, Manli Hu, Song Tian, Junjie Zhou, Maoji Yin, Lei Luo, Long Zhang, Xu Cheng, Weiyi Qu, Yufeng Hu, Mario Chiong, Mayarling F Troncoso, Zhaoliang Shan, Hailong Yang, Hui Liu, Juan Wan, Xiao-Jing Zhang, Jingjing Cai, Zhi-Gang She, Xin Zhang, Hongliang Li

Zitieren

APA

Zhou, S., Liu, J., Hu, M., Tian, S., Zhou, J., Li, W., Chen, H., Yin, M., Wang, S., Luo, L., Zhang, L., Zhou, X., Cheng, X., Qiu, Q., Wang, J., Qu, W., Hu, Y., Ferdinandy, P., Chiong, M., …, & Li, H. (2026). Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury. Circulation. https://doi.org/10.1161/circulationaha.125.077971

Vancouver

Zhou S, Liu J, Hu M, Tian S, Zhou J, Li W, et al. Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury. Circulation. 2026. doi:10.1161/circulationaha.125.077971

BibTeX
@article{Zhou2026,
  author = {Zhou, Siyi and Liu, Jiayi and Hu, Manli and Tian, Song and Zhou, Junjie and Li, Wei and Chen, Hailian and Yin, Maoji and Wang, Shiyi and Luo, Lei and Zhang, Long and Zhou, Xiangqiang and Cheng, Xu and Qiu, Quanqing and Wang, Jinsheng and Qu, Weiyi and Hu, Yufeng and Ferdinandy, Péter and Chiong, Mario and Troncoso, Mayarling F and Shan, Zhaoliang and Bai, Lan and Yang, Hailong and Liu, Hui and Wan, Juan and Zhang, Xiao-Jing and Cai, Jingjing and She, Zhi-Gang and Zhang, Xin and Li, Hongliang},
  title = {Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury},
  journal = {Circulation},
  year = {2026},
  doi = {10.1161/circulationaha.125.077971}
}
Kostenlos starten →